Wegovys new 7.2mg dose (UK-approved January 2026) also narrows the gap, producing 20.7% average weight loss in its own trial
Why Weight Regain Occurs : Biological adaptations that promoted weight gain initially remain present Appetite and food preoccupation often return when medication stopped Metabolic rate may decrease during weight loss (adaptive thermogenesis) Hormonal changes that defend against weight loss persist Long-Term Management : Most individuals require ongoing medication for sustained weight loss maintenance This is similar to other chronic disease treatments (e.g., blood pressure medications) Obesity is a chronic disease requiring long-term management Strong lifestyle habits help minimize regain but may not prevent it entirely Discuss any plans to discontinue medication with healthcare provider to develop appropriate tapering plan and maintenance strategies
These findings further underscore its utility as a research agent for exploring both acute and long-term glucose regulation
For researchers committed to understanding the full retatrutide cost picture and making informed decisions about their peptide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
As HAES therapists, we know weight is only one part of health, and not the most important one
